Glaukos
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Glaukos and other ETFs, options, and stocks.About GKOS
Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology.
CEOThomas William Burns
CEOThomas William Burns
Employees995
Employees995
HeadquartersAliso Viejo, California
HeadquartersAliso Viejo, California
Founded1998
Founded1998
Employees995
Employees995
GKOS Key Statistics
Market cap6.23B
Market cap6.23B
Price-Earnings ratio-69.97
Price-Earnings ratio-69.97
Dividend yield—
Dividend yield—
Average volume823.45K
Average volume823.45K
High today$112.00
High today$112.00
Low today$107.65
Low today$107.65
Open price$108.80
Open price$108.80
Volume453.03K
Volume453.03K
52 Week high$163.71
52 Week high$163.71
52 Week low$73.16
52 Week low$73.16
Stock Snapshot
The current Glaukos(GKOS) stock price is $108.51, with a market capitalization of 6.23B. The stock trades at a price-to-earnings (P/E) ratio of -69.97.
On 2025-12-06, Glaukos(GKOS) stock moved within a range of $107.65 to $112.00. With shares now at $108.51, the stock is trading +0.8% above its intraday low and -3.1% below the session's peak.
Trading activity shows a volume of 453.03K, compared to an average daily volume of 823.45K.
The stock's 52-week range extends from a low of $73.16 to a high of $163.71.
The stock's 52-week range extends from a low of $73.16 to a high of $163.71.
Analyst ratings
93%
of 15 ratingsBuy
93.3%
Hold
0%
Sell
6.7%
People also own
Based on the portfolios of people who own GKOS. This list is generated using Robinhood data, and it’s not a recommendation.